Concord Medical Services Holdings Limited

Total Valuation

Concord Medical Services Holdings Limited carries a market capitalization of 656,719.00, placing it among publicly traded companies globally. Its enterprise value stands at 2.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Concord Medical Services Holdings Limited currently has 132.99M shares outstanding.

Valuation Ratios

Concord Medical Services Holdings Limited trades at a trailing price-to-earnings ratio of 11.46. The price-to-sales ratio is 2.09, and the price-to-book ratio stands at -2.95.

Enterprise Valuation

On an enterprise value basis, Concord Medical Services Holdings Limited trades at an EV/EBITDA multiple of 170.40 and an EV/FCF ratio of 21.69. The EV/Sales ratio of 4.86 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 170.40 provides insight into valuation relative to core operating earnings.

Financial Position

Concord Medical Services Holdings Limited maintains a current ratio of 0.98, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 114.49, indicating elevated leverage, while an interest coverage ratio of -0.62 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Concord Medical Services Holdings Limited's stock has declined approximately -37.36111% over the past 52 weeks. The 50-day moving average sits at 4.35, while the 200-day moving average is 4.61.

Income Statement

Over the trailing twelve months, Concord Medical Services Holdings Limited generated 545.88M in revenue and converted that into -193.72M in net income, yielding earnings per share of -43.89. EBITDA reached -44.68M, while operating income came in at -44.68M.

Balance Sheet

Concord Medical Services Holdings Limited holds 164.01M in cash and equivalents against 1.60B in total debt, resulting in a net debt position of 1.43B. Total book value stands at -386.58M, with working capital of -33.47M providing operational flexibility.

Margins

Concord Medical Services Holdings Limited operates with a gross margin of 38.67, reflecting its pricing power and cost economics. The operating margin of -8.19 and net profit margin of -35.49 provide insight into operational efficiency.

Stock Splits

Concord Medical Services Holdings Limited's most recent stock split took place on July 30, 2024 with a 10:1 split ratio.

Scores

Concord Medical Services Holdings Limited posts an Altman Z-Score of 0.28, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.